305 related articles for article (PubMed ID: 23612879)
1. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
[TBL] [Abstract][Full Text] [Related]
2. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
3. Novel Genetic Variants Distinguishing Myelin Oligodendrocyte Glycoprotein-IgG-Positive From Myelin Oligodendrocyte Glycoprotein-IgG-Negative Pediatric Acute Disseminated Encephalomyelitis in Northern China.
Cui Y; Wu B; Wu J; Zhang S; Guo P; Shu J; Li D; Cai C
Pediatr Neurol; 2024 Jul; 156():155-161. PubMed ID: 38781724
[TBL] [Abstract][Full Text] [Related]
4. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
Hecker M; Fitzner B; Wendt M; Lorenz P; Flechtner K; Steinbeck F; Schröder I; Thiesen HJ; Zettl UK
Mol Cell Proteomics; 2016 Apr; 15(4):1360-80. PubMed ID: 26831522
[TBL] [Abstract][Full Text] [Related]
5. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of antibodies to myelin oligodendrocyte glycoprotein in demyelinating diseases of the central nervous system].
Shchepareva ME; Kochergin IA; Tolpeeva OA; Shabalina AA; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2. Vyp. 2):18-23. PubMed ID: 31156236
[TBL] [Abstract][Full Text] [Related]
7. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
[TBL] [Abstract][Full Text] [Related]
8. Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis.
Peschl P; Ramberger M; Höftberger R; Jöhrer K; Baumann M; Rostásy K; Reindl M
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28327523
[TBL] [Abstract][Full Text] [Related]
9. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
[TBL] [Abstract][Full Text] [Related]
10. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
O'Connor KC; McLaughlin KA; De Jager PL; Chitnis T; Bettelli E; Xu C; Robinson WH; Cherry SV; Bar-Or A; Banwell B; Fukaura H; Fukazawa T; Tenembaum S; Wong SJ; Tavakoli NP; Idrissova Z; Viglietta V; Rostasy K; Pohl D; Dale RC; Freedman M; Steinman L; Buckle GJ; Kuchroo VK; Hafler DA; Wucherpfennig KW
Nat Med; 2007 Feb; 13(2):211-7. PubMed ID: 17237795
[TBL] [Abstract][Full Text] [Related]
11. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
12. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects.
Lampasona V; Franciotta D; Furlan R; Zanaboni S; Fazio R; Bonifacio E; Comi G; Martino G
Neurology; 2004 Jun; 62(11):2092-4. PubMed ID: 15184621
[TBL] [Abstract][Full Text] [Related]
13. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Gaertner S; de Graaf KL; Greve B; Weissert R
Neurology; 2004 Dec; 63(12):2381-3. PubMed ID: 15623705
[TBL] [Abstract][Full Text] [Related]
16. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Lily O; Palace J; Vincent A
Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
[TBL] [Abstract][Full Text] [Related]
17. An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Numa S; Kasai T; Kondo T; Kushimura Y; Kimura A; Takahashi H; Morita K; Tanaka A; Noto Y; Ohara T; Nakagawa M; Mizuno T
Intern Med; 2016; 55(6):699-702. PubMed ID: 26984094
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
Greer JM; Trifilieff E; Pender MP
Front Immunol; 2020; 11():1891. PubMed ID: 32973782
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
